Ipatasertib Plus Abiraterone Plus Prednisone / Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone / Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer (IPATential150)

Status:

Closed to Accrual

III

Phase

1st

Line of Therapy

Advanced / Metastatic

Disease Stage

Biomarker(s)

N/A

Investigational

Product

Ipatasertib

AKT inhibitor (p.o.)

Treatment Arms

o Experimental: Ipatasertib + Abiraterone

o Active Comparator: Placebo + Abiraterone